The US Food and Drug Administration (FDA) approved Tekamlo (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine. Since Aliskiren is already in the market, it needs to be seen which one of the 3 classes of drugs tergeting the renin-angiotensin-aldosterone system (angiotensin receptor blockers, ACE inhibitors and renin inhibitors) is a better alternative for hypertensive patients. In our medical school we are initiating a trial comparing newer angiotensin receptor blockers and ACE inhibitors. I do not know whether aliskiren is available in India and at what cost.
Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
Subscribe to:
Post Comments (Atom)
Free Books, powerpoint presentations, teaching tools and resources and drug information
-
-
Is Vitapulse a Scam? - The heart is a vital organ of the body and it plays major roles in its general functioning. Proper healthcare should be taken to ensure the heart functio...8 years ago
-
Comparative Effect of Agomelatine versus Escitalopram on Glycemic Control and Symptoms of Depression in Patients with Type 2 Diabetes Mellitus and Depression - Kumar K, Salman MT, Shukla V, Ahmad A, Verma V K, Rizvi D A and Kohli A: Comparative Effect of Agomelatine versus Escitalopram on Glycemic Control and Symp...8 years ago
-
For Computer-lOvErS - *Antivirus SofTwArEs* Norton 360 (Up To 12 Years Key) Norton AntiVirus 2008 AVG Antivirus Panda.Antivirus NOD32 Antivirus Kingsoft Antivirus Kaspersky...15 years ago
-
Contemporary Targeted Therapies in Rheumatology - Publisher: Informa Healthcare Number Of Pages: 636 Publication Date: 2007-10-24 ISBN-10 / ASIN: 1841844845 ISBN-13 / EAN: 9781841844848 Binding: Hardcover ...15 years ago
-
-
-
-
-
-
-
-
No comments:
Post a Comment
Add your comment